Equities

Tianda Pharmaceuticals Ltd

Tianda Pharmaceuticals Ltd

Actions
  • Price (HKD)0.237
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+12.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments162343235
Total Receivables, Net106143148
Total Inventory654864
Prepaid expenses1.811.998.14
Other current assets, total8.4322151
Total current assets344558606
Property, plant & equipment, net413401379
Goodwill, net9596103
Intangibles, net553238
Long term investments9.220.746.87
Note receivable - long term------
Other long term assets------
Total assets9171,0881,133
LIABILITIES
Accounts payable1067188
Accrued expenses647160
Notes payable/short-term debt000
Current portion long-term debt/capital leases1027023
Other current liabilities, total4115043
Total current liabilities313362214
Total long term debt1171122
Total debt114141146
Deferred income tax0.610.965.97
Minority interest(0.13)2634
Other liabilities, total00.090.30
Total liabilities325461377
SHAREHOLDERS EQUITY
Common stock215215215
Additional paid-in capital356356356
Retained earnings (accumulated deficit)111141225
Treasury stock - common------
Unrealized gain (loss)(12)(11)(4.85)
Other equity, total(78)(73)(34)
Total equity592628757
Total liabilities & shareholders' equity9171,0881,133
Total common shares outstanding2,1502,1502,150
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.